阿兹提丁通过阻断菌组合来杀死多药耐药的Mycobacterium结核病而没有可检测的抗性
Yixin Cui1, Alice Lanne2, Xudan Peng3
1School of Chemistry, University of Birmingham, Edgbaston, Birmingham, West Midlands B15 2TT, U.K.
Journal of medicinal chemistry
|February 8, 2024
概括
新的阿兹提丁衍生物BGAz显示出强大的杀菌活性,对抗药物敏感性和多药耐药结核病 (TB). 这些化合物向细胞包膜生物发生,为结核病治疗提供了一种新的治疗方法.
科学领域:
- 药用化学 医学化学
- 微生物学 微生物学
- 药物发现 药物发现 药物发现
背景情况:
- 结核病 (TB) 仍然是全球主要的传染病,导致严重的发病率和死亡率.
- 多耐药性 (MDR-TB) 和广泛耐药性 (XDR-TB) 菌株的增加需要紧急开发新的抗结核病药物.
- 由于耐药性和毒性,现有的治疗方法面临挑战,这凸显了需要新的药物点和化学支架的需要.
研究的目的:
- 识别具有针对Mycobacterium tuberculosis的强有力的活性的新型化学实体.
- 调查新发现化合物的作用机制和耐药性概况.
- 评估这些化合物作为抗结核化疗的临床前潜力.
主要方法:
- 对抗Mycobacterium tuberculosis的亚齐丁丁衍生物 (BGAz) 的全细胞表型查.
- 确定对药物敏感菌株和MDR-TB菌株的最小抑制度 (MIC99) 值.
- 行动研究的机制,包括目标解卷和转录基因分析.
- 对毒理学和药理动力学/药理动力学 (PK/PD) 资料的评估.
主要成果:
- 一系列阿兹提丁衍生物 (BGAz) 显示出强大的杀菌活性 (MIC99<10μM) 对药物敏感性和MDR-TB.
- 在BGAz化合物中没有观察到可检测的耐药性.
- 研究表明,BGAz化合物抑制了晚期菌酸生物合成,这是菌细胞外的关键组成部分.
- 转录组分析显示,与现有的细胞壁抑制剂相比,它具有不同的作用模式.
- 观察到有前途的毒理学和PK/PD概况,支持进一步发展.
结论:
- BGAz衍生物代表了一种新型的化合物类别,在结核病治疗中具有显著的潜力.
- 它们独特的作用机制向细胞包膜生物发生,比现有疗法提供了优势.
- 良好的临床前资料表明,BGAz化合物是进一步抗结核药物开发的可行候选者.
更多相关视频
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
10.5K
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
8.6K
相关概念视频
Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Destabilization of Microtubules
2.7K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.7K
